Skip to main content

Table 1 Characteristics of patients with HCC

From: Transarterial chemoembolization (TACE) using mitomycin and lipiodol with or without degradable starch microspheres for hepatocellular carcinoma: comparative study

No. of patients

99

Patients age (years)

63.6 (range: 34-83 years)

Male no. (%)

78 (78.8%)

Female no. (%)

21 (21.2%)

Presence of liver cirrhosis (%)

91 (91.9%)

Initial liver disease:

 Hepatitis B

29 (29.3%)

 Hepatitis C

36 (36.4%)

 Hepatitis B and C

9 (9.1%)

 Hemochromatosis

3 (3.0%)

 Alcohol abusus

26 (26.3%)

BCLC-Stage:

 BCLC-Stage A

11 (11.1%)

 BCLC-Stage B

88 (91.9%)

Child-Pugh class:

 A

27 (27.3%)

 B

72 (72.7%)

 Vascular tumor invasion

0%

Confirmation of diagnosis with liver

 Biopsie

99 (100%)

Localisation in liver:

 Right lobar

45% (45.5%)

 Left lobe

5 (5.1%)

 Bilobar

49 (49.4%)

Number of tumor lesions:

 Single

11 (11.1%)

 2

28 (28.3%)

 3

8 (8.1%)

 4

4 (4%)

 Multifocal

48 (48.5%)

Tumor response:

 Partial response

25 (25.3%)

 Stable disease

54 (54.5%)

 Progressive disease

20 (20.2%)